| Biomarker ID | 1148 |
| PMID | 23818401 |
| Year | 2013 |
| Biomarker | C-Reactive Protein (CRP) |
| Biomarker Basis | Concentration Based |
| Biomolecule | Protein |
| Source | Serum |
| Subjects | Humans |
| Regulation | Higher levels associated with shorter biochemical failure-free survival (Both for patients with Post- radical Prostatectomy and Definitive Radiotherapy) |
| Odds Ratio/Hazard Ratio/Relative Risk | Definitive Radiation Therapy: HR: 2.03 (95% CI: 1.19-3.47) |
| Effect on Pathways | NA |
| Experiment | Biochemical Failure Free survival |
| Type of Biomarker | Prognostic |
| Cohort | 206 patients who received radiation therapy for adenocarcinoma of the prostate were included in the study |
| Senstivity | NA |
| Specificity | NA |
| AUC | NA |
| Accuracy | NA |
| Level Of Significance | p = 0.009 |
| Method Used | NA |
| Clinical | No |
| Remarks | NA |
| Clinical Trial Number | NA |
| Degree Of Validity | Not validated on independent patient dataset |
| Technical Name | NA |